HAP Trading’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 943 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1078 |
|
|
2022
Q1 | – | Sell |
-9,996
| Closed | -$265K | – | 1200 |
|
|
2021
Q4 | $265K | Sell |
9,996
-1,946
| -16% | -$51.6K | 0.01% | 478 |
|
|
2021
Q3 | $434K | Buy |
11,942
+826
| +7% | +$30K | 0.01% | 421 |
|
|
2021
Q2 | $482K | Sell |
11,116
-1,327
| -11% | -$57.5K | 0.02% | 386 |
|
|
2021
Q1 | $426K | Buy |
12,443
+1,851
| +17% | +$63.4K | 0.02% | 299 |
|
|
2020
Q4 | $371K | Buy |
10,592
+592
| +6% | +$20.7K | 0.01% | 336 |
|
|
2020
Q3 | $240K | Buy |
+10,000
| New | +$240K | 0.01% | 258 |
|
|
2020
Q1 | – | Sell |
-9,893
| Closed | -$212K | – | 713 |
|
|
2019
Q4 | $212K | Buy |
+9,893
| New | +$212K | 0.01% | 233 |
|
|
2016
Q4 | – | Sell |
-30,757
| Closed | -$1.13M | – | 537 |
|
|
2016
Q3 | $1.13M | Buy |
+30,757
| New | +$1.13M | 0.04% | 157 |
|